P-208Phase II study in progress to verify improved response with mFOLFOX6 after exposure to an immune checkpoint inhibitor in advanced gastric cancer. (2nd July 2019) - Ann, H; Manaka, D; Konishi, S; Ikeda, Y; Ota, T; Kudo, R; Kawaguchi, K; Sasaki, N; Hamasu, S; Nishitai, R